Fryderyk Lorenz

Contact

Works at

Affiliated as other position at Department of Diagnostics and Intervention Section: Oncology

G41 vån 4, NUS, Hematologiska sektionen Umeå universitet, 901 85 Umeå

Publications Publications

“Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)”

Leukemia, Springer Nature 2022, Vol. 36 : 1436-1439

Rasmussen, Bengt; Göhring, Gudrun; Bernard, Elsa; et al.

Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study

British Journal of Haematology, John Wiley & Sons 2021, Vol. 192, (3) : 474-483

Moreno Berggren, Daniel; Kjellander, Matilda; Backlund, Ellen; et al.

Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged >= 60 years

British Journal of Haematology, John Wiley & Sons 2020, Vol. 189, (1) : e13-e16

Österroos, Albin; Eriksson, Anna; Antunovic, Petar; et al.

Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register

British Journal of Haematology, Vol. 181, (5) : 614-627

Berggren, Daniel Moreno; Folkvaljon, Yasin; Engvall, Marie; et al.

Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience

Leukemia and Lymphoma, Taylor & Francis 2018, Vol. 59, (8) : 1840-1850

Lorenz, Fryderyk; Klimkowska, Monika; Pawłowicz, Ewa; et al.

Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1

Blood Cells, Molecules & Diseases, ACADEMIC PRESS INC ELSEVIER SCIENCE 2018, Vol. 68 : 35-42

Lorenz, Fryderyk; Pawlowicz, Ewa; Klimkowska, Monika; et al.

Hyperferritinemia and serum inflammatory cytokines in 71 adults with newly diagnosed hemophagocytic lymphohistiocytosis associated with hematological malignancy

Haematologica, Ferrata Storti Foundation 2017, Vol. 102 : 761-761

Machaczka, M.; Lorenz, Fryderyk; Pawlowicz, E.; et al.

VALIDATION OF PROGNOSTIC SCORING SYSTEMS FOR MYELODYSPLASTIC SYNDROMES IN THE SWEDISH MDS-REGISTER

Haematologica, Vol. 101 : 243-243

Berggren, D. Moreno; Folkvaljon, Y.; Engvall, M.; et al.

HYPERFERRITINEMIA AND SERUM INFLAMMATORY CYTOKINES IN ADULTS WITH GAUCHER DISEASE TYPE 1

Haematologica, Vol. 101, (S1) : 580-581

Lorenz, Fryderyk; Pawlowicz, E.; Bjorkvall, C. Kampe; et al.

Wartosc diagnostyczna i zastosowanie kliniczne biomarkerów oraz ferrytynemii w chorobie Gauchera: [Diagnostic and clinical value of biomarkers and ferritinemia in Gaucher disease]

Acta Haematologica Polonica, Elsevier 2014, Vol. 45, (2) : 149-154

Lorenz, Fryderyk; Skotnicki, Aleksander B.; Machaczka, Maciej

Recurrent pulmonary aspergillosis and mycobacterial infection in an unsplenectomized patient with type 1 Gaucher disease

Upsala Journal of Medical Sciences, Informa Healthcare 2014, Vol. 119, (1) : 44-49

Machaczka, Maciej; Lorenz, Fryderyk; Kleinotiene, Grazina; et al.

Długotrwała pancytopenia po chemioterapii jako objaw demaskuja̧cy chorobȩ Gauchera u pacjentki z rakiem płuca: [Long-lasting pancytopenia after chemotherapy as a disclosing symptom of Gaucher disease in a patient with lung cancer]

Acta Haematologica Polonica, Elsevier 2014, Vol. 45, (3) : 294-300

Markuszewska-Kuczymska, Alicja; Kämpe Björkvall, Cecilia; Lorenz, Fryderyk; et al.

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

European Journal of Haematology, Vol. 93, (5) : 439-445

Svensson, Tobias; Chowdhury, Onima; Garelius, Hege; et al.

Reduction in WT1 Gene Expression During Early Treatment Predicts the Outcome in Patients With Acute Myeloid Leukemia

Diagnostic molecular pathology (Print), Lippincott Williams & Wilkins 2012, Vol. 21, (4) : 225-233

Andersson, Charlotta; Li, Xingru; Lorenz, Fryderyk; et al.

Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts.

Medical Oncology, Vol. 28, (2) : 552-558

Wahlin, Anders; Lorenz, Fryderyk; Fredriksson, Maritha; et al.

View publications in DiVA